Effectiveness of pulmonary rehabilitation in COVID-19 respiratory failure patients post-ICU

Y Al Chikhanie1, D Veale1, M Schoeffler2

  • 1Pulmonary Rehabilitation Center Dieulefit santé, Dieulefit, Rhône-Alpes, France; HP2 Laboratory, INSERM, Grenoble Alpes University, Grenoble, Rhône-Alpes, France.

Insights

Pulmonary rehabilitation (PR) significantly improved walking distance in COVID-19 patients after intensive care unit (ICU) admission. Early PR led to better recovery, though some physical and psychosocial impairments persisted.

Area of Science:

  • Critical Care Medicine
  • Pulmonology
  • Rehabilitation Medicine

Background:

  • COVID-19 can cause respiratory failure requiring intensive care unit (ICU) admission.
  • Post-ICU patients often experience significant functional impairments.
  • Pulmonary rehabilitation (PR) is a key intervention for respiratory failure recovery.

Purpose of the Study:

  • To evaluate the effectiveness of PR in COVID-19 patients following ICU discharge.
  • To compare PR outcomes in COVID-19 patients versus non-COVID-19 respiratory failure patients.
  • To determine the impact of timing of PR on recovery.

Main Methods:

  • Retrospective study comparing 21 COVID-19 patients with 21 non-COVID-19 respiratory failure patients.
  • Patients underwent PR post-ICU admission.
  • Evaluations included pre- and post-PR assessments, focusing on 6-minute walking distance.

Main Results:

  • COVID-19 patients showed a greater improvement in 6-minute walking distance (+205m) compared to non-COVID-19 patients (+93m) after PR.
  • Earlier initiation of PR post-ICU correlated with better patient recovery.
  • Significant functional gains were observed in COVID-19 survivors.

Conclusions:

  • Pulmonary rehabilitation yields substantial functional improvements for COVID-19 survivors post-ICU.
  • Despite PR benefits, persistent physical and psychosocial deficits remain a concern.
  • Timely PR is crucial for optimizing recovery in critically ill COVID-19 patients.
Abstract

Related Concept Videos

Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
293
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
579
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
2.9K
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
730
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
562
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
428